CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2025-05-14 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2024-05-15 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-01-03 | Ekman Lars Director | Option exercise | +15,834 | $6.41 | $101K | 16,077 |
| 2023-01-03 | Ekman Lars Director | Sale | −3,411 | $54.15 | $185K | 12,666 |
| 2023-01-03 | Ekman Lars Director | Sale | −2,897 | $55.35 | $160K | 9,769 |
| 2023-01-03 | Ekman Lars Director | Sale | −6,621 | $56.33 | $373K | 3,148 |
| 2023-01-03 | Ekman Lars Director | Sale | −1,303 | $56.98 | $74K | 1,845 |
| 2023-01-03 | Ekman Lars Director | Sale | −1,523 | $58.67 | $89K | 322 |
| 2023-01-03 | Ekman Lars Director | Sale | −10 | $59.46 | $595 | 312 |
| 2023-01-03 | Ekman Lars Director | Sale | −69 | $60.85 | $4K | 243 |
| 2023-01-03 | Ekman Lars Director | Option exercise · Stock Option (right to buy) | −15,834 | 0 | ||
| 2022-12-01 | Ekman Lars Director | Option exercise | +15,834 | $6.41 | $101K | 16,077 |
| 2022-12-01 | Ekman Lars Director | Sale | −9,813 | $61.28 | $601K | 6,264 |
| 2022-12-01 | Ekman Lars Director | Sale | −6,021 | $62.12 | $374K | 243 |
| 2022-12-01 | Ekman Lars Director | Option exercise · Stock Option (right to buy) | −15,834 | 15,834 | ||
| 2022-11-01 | Ekman Lars Director | Option exercise | +15,833 | $6.41 | $101K | 16,076 |
| 2022-11-01 | Ekman Lars Director | Sale | −9,143 | $62.01 | $567K | 6,933 |
| 2022-11-01 | Ekman Lars Director | Sale | −1,717 | $62.91 | $108K | 5,216 |
Page 1 of 2 · 33 trades